Top Story

Average vocal pitch decrease linked to testosterone dosing

April 17, 2015

Dose- and concentration-dependent decrease in average vocal pitch was found among women with higher levels of testosterone administration over 24 weeks, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Grace Huang, MD, of Brigham and Women’s Hospital in Brookline, Massachusetts, and colleagues evaluated 71 women who underwent hysterectomy with or without oophorectomy with total testosterone less than 31 ng/dL and/or free testosterone less than 3.5 pg/mL to determine the dose-dependent effects of testosterone administration on voice changes in this population.

In the Journals

Preterm infants show increased adiponectin levels in first weeks of life

April 17, 2015
In very preterm infants, blood concentrations of adiponectin appear to increase significantly within the first 3 weeks of life, according to recent findings. In an…
In the Journals

Risk for sudden deafness higher among patients with osteoporosis

April 17, 2015
Sudden sensorineural hearing loss development is increased among people diagnosed with osteoporosis, according to recent study findings published in The Journal of
In the Journals

Autonomic imbalance may predict multiple poor metabolic outcomes

April 17, 2015
Resting heart rate and heart rate variability may serve as predictors for certain metabolic risk outcomes and diabetes, according to research in The Journal of Clinical
Obama signs Medicare Access and CHIP Reauthorization Act of 2015 into law Health Care Legislative and Regulatory Update

Obama signs Medicare Access and CHIP Reauthorization Act of 2015 into law

April 16, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
thumbnail for video 4145380494001

Researcher: Vitiligo comorbidities include thyroid disease, alopecia, psoriasis and lupus

March 31, 2015
SAN FRANCISCO — In this video, Iltefat Hamzavi, MD, FAAD, senior staff physician at Henry Ford Hospital…
More »
CME
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan